Abstract
Epilepsy represents a hazardous neurological disorder, underpinned by a pathophysiological process that is yet to be fully understood. Here, we aimed to elucidate the effect of methyl-CpG-binding domain protein 3 (MBD3) on hippocampal neuronal damage in epileptic mice by targeting the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway. The expression of MBD3 was determined by Western blot in a hippocampal neuronal culture (HNC) epileptic model established using the low Mg2+ECF culture method. The interaction between MBD3 and DNA methyltransferase 1 (DNMT1) was determined via co-immunoprecipitation and mass spectrometry analysis. Bisulfite modification and sequencing was performed to evaluate the degree of methylation of triggering receptor expressed on myeloid cells 2 (TREM2). The viability and apoptosis of hippocampal neurons were detected by CCK-8 and TUNEL assays, respectively. Finally, the effect of MBD3 was verified in vivo. MBD3 was highly expressed in the HNC model of epilepsy, with its interaction with DNMT1 found to promote the hypermethylation of TREM2 at site cg25748868. Additionally, decreased TREM2 and inhibited PI3K/Akt pathway was observed in the HNC epileptic model. Simultaneous inhibition of MBD3 and DNMT1 decreased the methylation level at cg25748868, up-regulated TREM2 expression, and activated the PI3K/Akt pathway, thereby arresting neuronal damage. Inhibition of MBD3 reduced the level of epileptic seizures, down-regulated cg25748868 methylation, activated TREM2-mediated signaling pathways, and alleviated hippocampal neuronal damage in the acute seizure mouse models. The present study unveiled that MBD3 and DNMT1 synergistically enhanced hypermethylation of cg25748868 in TREM2, and promoted the onset of epilepsy via inhibition of the PI3K/Akt pathway.
Similar content being viewed by others
Data Availability
The datasets supporting the conclusions of this article are available.
References
Johnson EL (2019) Seizures and epilepsy. Med Clin North Am 103(2):309–324
Moshe SL, Perucca E, Ryvlin P et al (2015) Epilepsy: new advances. Lancet 385(9971):884–898
Devinsky O, Vezzani A, O’Brien TJ et al (2018) Epilepsy. Nat Rev Dis Primers 4:18024
Thijs RD, Surges R, O’Brien TJ et al (2019) Epilepsy in adults. Lancet 393(10172):689–701
Loscher W, Klitgaard H, Twyman RE et al (2013) New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 12(10):757–776
Oto MM (2017) The misdiagnosis of epilepsy: appraising risks and managing uncertainty. Seizure 44:143–146
Du Q, Luu PL, Stirzaker C et al (2015) Methyl-CpG-binding domain proteins: readers of the epigenome. Epigenomics 7(6):1051–1073
Leighton G, Williams DC (2019) The methyl-CpG-binding domain 2 and 3 proteins and formation of the nucleosome remodeling and deacetylase complex. J Mol Biol 432(6):1624–1639
Bednarczyk J, Debski KJ, Bot AM et al (2016) MBD3 expression and DNA binding patterns are altered in a rat model of temporal lobe epilepsy. Sci Rep 6:33736
Cai Y, Geutjes EJ, de Lint K et al (2014) The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes. Oncogene 33(17):2157–2168
Kobow K, Kaspi A, Harikrishnan KN et al (2013) Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol 126(5):741–756
Jin SC, Benitez BA, Karch CM et al (2014) Coding variants in TREM2 increase risk for Alzheimer’s disease. Hum Mol Genet 23(21):5838–5846
Jonsson T, Stefansson H, Steinberg S et al (2013) Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med 368(2):107–116
Kawabori M, Kacimi R, Kauppinen T et al (2015) Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J Neurosci 35(8):3384–3396
Liu AH, Chu M, Wang YP (2019) Up-regulation of Trem2 inhibits hippocampal neuronal apoptosis and alleviates oxidative stress in epilepsy via the PI3K/Akt pathway in mice. Neurosci Bull 35(3):471–485
Lunnon K, Smith R, Hannon E et al (2014) Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer’s disease. Nat Neurosci 17(9):1164–1170
Smith AR, Smith RG, Condliffe D et al (2016) Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer’s disease brain. Neurobiol Aging 47:35–40
Xie N, Wang C, Wu C et al (2016) Mdivi-1 protects epileptic hippocampal neurons from apoptosis via inhibiting oxidative stress and endoplasmic reticulum stress in vitro. Neurochem Res 41(6):1335–1342
Srinivasan S, Stevens M, Wiley JW (2000) Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49(11):1932–1938
Ma DL, Qu JQ, Goh EL et al (2015) Reorganization of basolateral amygdala-subiculum circuitry in mouse epilepsy model. Front Neuroanat 9:167
Chatzikonstantinou A (2014) Epilepsy and the hippocampus. Front Neurol Neurosci 34:121–142
Pitkanen A, Loscher W, Vezzani A et al (2016) Advances in the development of biomarkers for epilepsy. Lancet Neurol 15(8):843–856
Shetty AK (2014) Hippocampal injury-induced cognitive and mood dysfunction, altered neurogenesis, and epilepsy: can early neural stem cell grafting intervention provide protection? Epilepsy Behav 38:117–124
Kobow K, Blumcke I (2014) Epigenetic mechanisms in epilepsy. Prog Brain Res 213:279–316
Unnikrishnan A, Freeman WM, Jackson J et al (2019) The role of DNA methylation in epigenetics of aging. Pharmacol Ther 195:172–185
Greenberg MVC, Bourc’his D (2019) The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol 20(10):590–607
Qureshi IA, Mehler MF (2010) Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis 39(1):53–60
Zhu Q, Wang L, Zhang Y et al (2012) Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy. J Mol Neurosci 46(2):420–426
de Nijs L, Choe K, Steinbusch H et al (2019) DNA methyltransferase isoforms expression in the temporal lobe of epilepsy patients with a history of febrile seizures. Clin Epigenetics 11(1):118
Lin N, Qin S, Luo S et al (2014) Homocysteine induces cytotoxicity and proliferation inhibition in neural stem cells via DNA methylation in vitro. FEBS J 281(8):2088–2096
Becker AJ (2018) Review: animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis. Neuropathol Appl Neurobiol 44(1):112–129
Liu K, Lei M, Wu Z et al (2019) Structural analyses reveal that MBD3 is a methylated CG binder. FEBS J 286(16):3240–3254
Stefaniuk M, Lukasiuk K (2010) Cloning of expressed sequence tags (ESTs) representing putative epileptogenesis-related genes and the localization of their expression in the normal brain. Neurosci Lett 482(3):230–234
Painter MM, Atagi Y, Liu CC et al (2015) TREM2 in CNS homeostasis and neurodegenerative disease. Mol Neurodegener 10:43
Mecca C, Giambanco I, Donato R et al (2018) Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes. Int J Mol Sci 19(1):318
Xu P, Zhang X, Liu Q et al (2019) Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke. Cell Death Dis 10(8):555
Wu R, Li X, Xu P et al (2017) TREM2 protects against cerebral ischemia/reperfusion injury. Mol Brain 10(1):20
Li C, Zhao B, Lin C et al (2019) TREM2 inhibits inflammatory responses in mouse microglia by suppressing the PI3K/NF-kappaB signaling. Cell Biol Int 43(4):360–372
Davies MA (2012) The role of the PI3K-AKT pathway in melanoma. Cancer J 18(2):142–147
Kretz A, Happold CJ, Marticke JK et al (2005) Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci 29(4):569–579
Acknowledgements
We would like to acknowledge the reviewers for their helpful comments on this paper.
Funding
This work was supported by Research and Innovation Fund of Harbin Medical University (No. 2020L06), National Natural Science Foundation of China (Nos. 81601130 & 81772678), and Foundation of Heilongjiang Health and Family Planning Commission (No. 2018375).
Author information
Authors and Affiliations
Contributions
MN and HYW designed the study. WZ, ZBH and SKY collated the data, carried out data analyses and produced the initial draft of the manuscript. YMF and JYS revised the figures and tables. YFG, XBC, and ZGL contributed to drafting the manuscript. All authors have read and approved the final submitted manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no actual or potential conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
11064_2021_3371_MOESM1_ESM.eps
Supplementary file1 Validation of the HNC model by the whole-cell patch clamp technology. Note: in the presence of 300 mmol/L CRS, the whole-cell patch clamp technique was used to measure the current of normal cells and modeled cells for 15 min and the electricity was recorded. (EPS 1158 kb)
Rights and permissions
About this article
Cite this article
Wang, H., Feng, Y., Sun, J. et al. Methyl-CpG-Binding Domain Protein 3 Promotes Seizures by Recruiting Methyltransferase DNMT1 to Enhance TREM2 Methylation. Neurochem Res 46, 2451–2462 (2021). https://doi.org/10.1007/s11064-021-03371-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-021-03371-5